73 related articles for article (PubMed ID: 16110477)
1. Dispersal of epithelial cancer cell colonies by lysophosphatidic acid (LPA).
Jourquin J; Yang N; Kam Y; Guess C; Quaranta V
J Cell Physiol; 2006 Feb; 206(2):337-46. PubMed ID: 16110477
[TBL] [Abstract][Full Text] [Related]
2. Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions.
Lamorte L; Royal I; Naujokas M; Park M
Mol Biol Cell; 2002 May; 13(5):1449-61. PubMed ID: 12006644
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid-depleted serum, hepatocyte growth factor and stem cell growth factor stimulate colony growth of small cell lung cancer cells through a calcium-independent pathway.
Seckl MJ; Seufferlein T; Rozengurt E
Cancer Res; 1994 Dec; 54(23):6143-7. PubMed ID: 7525056
[TBL] [Abstract][Full Text] [Related]
4. Cell-scatter assay.
Chen HC
Methods Mol Biol; 2005; 294():69-77. PubMed ID: 15576906
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid induces ovarian cancer cell dispersal by activating Fyn kinase associated with p120-catenin.
Huang RY; Wang SM; Hsieh CY; Wu JC
Int J Cancer; 2008 Aug; 123(4):801-9. PubMed ID: 18506685
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells.
Hasegawa Y; Murph M; Yu S; Tigyi G; Mills GB
Mol Oncol; 2008 Jun; 2(1):54-69. PubMed ID: 19081821
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
[TBL] [Abstract][Full Text] [Related]
9. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells.
Shida D; Kitayama J; Yamaguchi H; Hama K; Aoki J; Arai H; Yamashita H; Mori K; Sako A; Konishi T; Watanabe T; Sakai T; Suzuki R; Ohta H; Takuwa Y; Nagawa H
Exp Cell Res; 2004 Dec; 301(2):168-78. PubMed ID: 15530853
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway.
Bian D; Su S; Mahanivong C; Cheng RK; Han Q; Pan ZK; Sun P; Huang S
Cancer Res; 2004 Jun; 64(12):4209-17. PubMed ID: 15205333
[TBL] [Abstract][Full Text] [Related]
12. Effect of scatter factor on motility of epithelial cells and fibroblasts.
Stoker M
J Cell Physiol; 1989 Jun; 139(3):565-9. PubMed ID: 2525565
[TBL] [Abstract][Full Text] [Related]
13. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
So J; Wang FQ; Navari J; Schreher J; Fishman DA
Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid regulates the motility of MCF10CA1a breast cancer cell sheets via two opposing signaling pathways.
Stuelten CH; Lee RM; Losert W; Parent CA
Cell Signal; 2018 May; 45():1-11. PubMed ID: 29337044
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase A inhibits lysophosphatidic acid induction of serum response factor via alterations in the actin cytoskeleton.
Nguyen GH; French R; Radhakrishna H
Cell Signal; 2004 Oct; 16(10):1141-51. PubMed ID: 15240009
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor.
Xu KP; Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):636-43. PubMed ID: 17251460
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium.
Nusrat A; Parkos CA; Bacarra AE; Godowski PJ; Delp-Archer C; Rosen EM; Madara JL
J Clin Invest; 1994 May; 93(5):2056-65. PubMed ID: 8182137
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.
Ren J; Xiao YJ; Singh LS; Zhao X; Zhao Z; Feng L; Rose TM; Prestwich GD; Xu Y
Cancer Res; 2006 Mar; 66(6):3006-14. PubMed ID: 16540649
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK.
Stähle M; Veit C; Bachfischer U; Schierling K; Skripczynski B; Hall A; Gierschik P; Giehl K
J Cell Sci; 2003 Sep; 116(Pt 18):3835-46. PubMed ID: 12902401
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid decreases epidermal growth factor receptor binding in airway epithelial cells.
Kassel KM; Schulte NA; Parker SM; Lanik AD; Toews ML
J Pharmacol Exp Ther; 2007 Oct; 323(1):109-18. PubMed ID: 17640953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
